Replies to post #128515 on Biotech Values

[iwfal]

so will the same happen to mC? I seriously doubt MNTA will settle - it will set undesired precedent.

Seriously - any delay/exclusivity of more than, say, 5 years seems highly unlikely. As I noted before, eventually the other generic's will find away around the patent (e.g. find a proxy acceptable to the FDA ...).